Agile Therapeutics to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Wednesday, March 30, 2022
Agile Therapeutics (Nasdaq: AGRX) plans to release its fourth quarter and full year 2021 financial results on March 30, 2022, after the market closes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Agile Therapeutics (Nasdaq: AGRX) plans to release its fourth quarter and full year 2021 financial results on March 30, 2022, after the market closes. A live conference call will follow at 4:30 p.m. ET, during which the company will discuss its results and provide business updates. Interested investors can access the call via telephone or through a webcast available on the company's investor relations page. This announcement highlights Agile Therapeutics' commitment to transparency and investor engagement.
Positive
- The upcoming financial results announcement might provide insights into revenue performance and potential growth.
- Hosting a live conference call demonstrates Agile's dedication to investor communication and transparency.
Negative
- None.
Details
News Market Reaction – AGRX
The recorded move for AGRX in the trading session of this news was -9.64%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live Conference Call and Webcast at 4:30 p.m. ET
PRINCETON, N.J., March 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2021 financial results after the market close on Wednesday, March 30, 2022. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update.
| Date | Wednesday, March 30, 2022 |
| Time | 4:30 p.m. ET |
| Webcast (live and archived) | Events & Presentations |
| Dial-in numbers | (833) 979-2857 (U.S. toll-free) or (236) 714-2948 |
| Conference ID | 7088441 |
Investors interested in listening to the conference call may do so by dialing (833) 979-2857 for domestic callers or (236) 714-2948 for international callers. A live webcast will be available in the Events and Presentations section of the Investor Relations page at https://ir.agiletherapeutics.com/events-and-presentations/, or by clicking here.
Please log in approximately 10 minutes prior to the scheduled start time. The archived webcast will be available in the Events and Presentations section of the company's website.
About Agile Therapeutics, Inc.
Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.